Handelsbanken Fonder’s Cantel Medical Corporation CMD Stock Holding History

Handelsbanken Fonder’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,337	Closed	-$506K	–	1733
2021 Q1	$506K	Hold	6,337	–	–	﹤0.01%	1193
2020 Q4	$500K	Hold	6,337	–	–	﹤0.01%	1159
2020 Q3	$278K	Hold	6,337	–	–	﹤0.01%	1281
2020 Q2	$280K	Buy	+6,337	New	+$236K	﹤0.01%	1257

Handelsbanken Fonder's CMD Position: Q2 2021 in Review

Handelsbanken Fonder sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,337 shares — an estimated $506K sold.

Handelsbanken Fonder first reported a position in CMD in Q2 2020 and held it in 4 quarters. The position peaked at $506K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Handelsbanken Fonder reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Handelsbanken Fonder sold 6,337 Cantel Medical Corporation shares in Q2 2021, an estimated $506K.
Handelsbanken Fonder first reported a position in Cantel Medical Corporation in Q2 2020 and held it in 4 quarters.
Handelsbanken Fonder's Cantel Medical Corporation position peaked at $506K in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Handelsbanken Fonder's 13F filing for Q2 2021, filed 3 Aug 2021.